STD Home > Emtricitabine/Rilpivirine/Tenofovir Information

Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (CompleraTM) is a medication licensed for the treatment of HIV and AIDS. It comes in tablet form and is taken once a day. This product is approved for use only in adults who have not taken any other HIV medications in the past. Because emtricitabine/rilpivirine/tenofovir contains three HIV medications, it is considered a complete regimen for HIV and AIDS treatment.
Although most people tolerate this medicine well, it is not suitable for everyone. Possible side effects may include headaches, insomnia, and increased cholesterol. Make sure to take this drug as prescribed, as missing doses can increase the chance of the virus becoming resistant to the medication.
Prior to taking emtricitabine/rilpivirine/tenofovir, make sure your healthcare provider has up-to-date information on any other drugs you are taking (including vitamins and supplements), as well as any allergies you may have, including to medications, foods, dyes, or preservatives. Also, let your healthcare provider know if you have any other medical issues, such as a history of depression, kidney problems, or liver disease.
(For more information, click Emtricitabine/Rilpivirine/Tenofovir. This full-length article provides information on how this drug works, dosing guidelines, and safety precautions to be aware of before beginning treatment.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.